Understanding mAb aggregation during low pH viral inactivation and subsequent neutralization
Autor: | James Angelo, Ruben Wälchli, Sebastian Vogg, Fabian Feidl, Zheng Jian Li, Jonathan Souquet, Sanchayita Ghose, Xavier Le Saoût, Hervé Broly, Mariana Ressurreição, Massimo Morbidelli, Xuankuo Xu |
---|---|
Rok vydání: | 2019 |
Předmět: |
0106 biological sciences
0301 basic medicine medicine.drug_class Bioengineering Context (language use) CHO Cells Protein aggregation Monoclonal antibody 01 natural sciences Applied Microbiology and Biotechnology Neutralization law.invention Protein Aggregates 03 medical and health sciences chemistry.chemical_compound Bioreactors Cricetulus law Cricetinae 010608 biotechnology medicine Animals Denaturation (biochemistry) Protein Unfolding Downstream processing Osmolar Concentration Antibodies Monoclonal Hydrogen-Ion Concentration ANS fluorescence Monoclonal antibodies Protein unfolding Viral inactivation Spectrometry Fluorescence 030104 developmental biology Monomer chemistry Recombinant DNA Biophysics Virus Inactivation Hydrophobic and Hydrophilic Interactions Biotechnology |
Zdroj: | Biotechnology and Bioengineering, 117 (3) |
ISSN: | 1097-0290 0006-3592 |
DOI: | 10.1002/bit.27237 |
Popis: | Monoclonal antibodies (mAbs) and related recombinant proteins continue to gain importance in the treatment of a great variety of diseases. Despite significant advances, their manufacturing can still present challenges owing to their molecular complexity and stringent regulations with respect to product purity, stability, safety, and so forth. In this context, protein aggregates are of particular concern due to their immunogenic potential. During manufacturing, mAbs routinely undergo acidic treatment to inactivate viral contamination, which can lead to their aggregation and thereby to product loss. To better understand the underlying mechanism so as to propose strategies to mitigate the issue, we systematically investigated the denaturation and aggregation of two mAbs at low pH as well as after neutralization. We observed that at low pH and low ionic strength, mAb surface hydrophobicity increased whereas molecular size remained constant. After neutralization of acidic mAb solutions, the fraction of monomeric mAb started to decrease accompanied by an increase on average mAb size. This indicates that electrostatic repulsion prevents denatured mAb molecules from aggregation under acidic pH and low ionic strength, whereas neutralization reduces this repulsion and coagulation initiates. Limiting denaturation at low pH by d-sorbitol addition or temperature reduction effectively improved monomer recovery after neutralization. Our findings might be used to develop innovative viral inactivation procedures during mAb manufacturing that result in higher product yields. |
Databáze: | OpenAIRE |
Externí odkaz: |